Professor Luis Paz-Ares explains the most important novelties in the field of lung cancer treatement after ESMO 2023.
- Early stage trails: ADAURA, ALINA, CheckMate 816, Keynote 671, CheckMate 017
- Stage III trial: PACIFIC-6
- STAGE IV trials: LIBRETTO-431, MARIPOSA, MARIPOSA-2, TROPION-Lung01
Video: https://medicaldigest.org/scientific-contents/interview:lung-cancer-highlights-esmo-2023-congress-2
